Diethylpropion Extended Release and Moxetumomab Pasudotox-tdfk
Determining the interaction of Diethylpropion Extended Release and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diethylpropion
Brand name: Tenuate, Tenuate Dospan
Synonyms: Diethylpropion
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diethylpropion Extended Release-Moxetumomab pasudotox-tdfk Intravenous
- Diethylpropion Extended Release-Moxifloxacin
- Diethylpropion Extended Release-Moxifloxacin (Systemic)
- Diethylpropion Extended Release-Moxifloxacin Hydrochloride
- Diethylpropion Extended Release-Moxifloxacin Injection
- Diethylpropion Extended Release-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Diethylpropion Hydrochloride
- Moxetumomab Pasudotox-tdfk-Diethylpropion Tablets
- Moxetumomab Pasudotox-tdfk-Difenoxin and Atropine
- Moxetumomab Pasudotox-tdfk-Differin
- Moxetumomab Pasudotox-tdfk-Differin (Adapalene)
- Moxetumomab Pasudotox-tdfk-Differin Cream